As of 2026-03-29, the Relative Valuation of Merck & Co Inc (MRK) is 141.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 119.63 USD, the upside of Merck & Co Inc based on Relative Valuation is 18.0%.
The range of the Relative Valuation is 125.57 - 176.31 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 23.9x | 18.8x |
| Forward P/E multiples | 16.2x - 20.5x | 18.5x |
| Fair Price | 125.57 - 176.31 | 141.20 |
| Upside | 5.0% - 47.4% | 18.0% |
| Date | P/E |
| 2026-03-27 | 16.20 |
| 2026-03-26 | 16.11 |
| 2026-03-25 | 16.17 |
| 2026-03-24 | 15.76 |
| 2026-03-23 | 15.67 |
| 2026-03-20 | 15.46 |
| 2026-03-19 | 15.47 |
| 2026-03-18 | 15.51 |
| 2026-03-17 | 15.69 |
| 2026-03-16 | 15.63 |
| 2026-03-13 | 15.66 |
| 2026-03-12 | 15.70 |
| 2026-03-11 | 15.74 |
| 2026-03-10 | 15.86 |
| 2026-03-09 | 15.86 |
| 2026-03-06 | 15.68 |
| 2026-03-05 | 15.72 |
| 2026-03-04 | 16.29 |
| 2026-03-03 | 16.23 |
| 2026-03-02 | 16.44 |
| 2026-02-27 | 16.77 |
| 2026-02-26 | 16.16 |
| 2026-02-25 | 16.59 |
| 2026-02-24 | 16.79 |
| 2026-02-23 | 16.77 |
| 2026-02-20 | 16.56 |
| 2026-02-19 | 16.51 |
| 2026-02-18 | 16.48 |
| 2026-02-17 | 16.47 |
| 2026-02-13 | 16.44 |
| 2026-02-12 | 16.15 |
| 2026-02-11 | 16.16 |
| 2026-02-10 | 15.87 |
| 2026-02-09 | 15.93 |
| 2026-02-06 | 16.51 |
| 2026-02-05 | 16.22 |
| 2026-02-04 | 16.03 |
| 2026-02-03 | 15.69 |
| 2026-02-02 | 15.36 |
| 2026-01-30 | 14.94 |
| 2026-01-29 | 14.67 |
| 2026-01-28 | 14.48 |
| 2026-01-27 | 14.62 |
| 2026-01-26 | 14.55 |
| 2026-01-23 | 14.65 |
| 2026-01-22 | 14.79 |
| 2026-01-21 | 15.05 |
| 2026-01-20 | 14.82 |
| 2026-01-16 | 14.74 |
| 2026-01-15 | 15.03 |